Cargando…

Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis

BACKGROUND: In 2011, the U.S. Department of Health and Human Services sent a letter to state Medicaid directors explaining the need for oversight of psychiatric prescriptions for children with mental health disorders. The National Committee for Quality Alliance proposed 3 quality measures for rating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramachandran, Sujith, Banahan, Benjamin F., Bentley, John P., West-Strum, Donna S., Patel, Amit S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398209/ https://www.ncbi.nlm.nih.gov/pubmed/27459658 http://dx.doi.org/10.18553/jmcp.2016.22.8.948

Ejemplares similares

Measuring Pharmacy Performance in the Area of Medication Adherence: Addressing the Issue of Risk Adjustment
por: Dharmarajan, Sai, et al.
Publicado: (2014)

Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis
por: Lokhandwala, Tasneem, et al.
Publicado: (2012)

Patterns of treatment for psychiatric disorders among children and adolescents in Mississippi Medicaid
por: Young, John, et al.
Publicado: (2019)

Adherence to Multiple Medications Prescribed for a Chronic Disease: A Methodological Investigation
por: Basak, Ramsankar, et al.
Publicado: (2014)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis
por: Ansell, B. R. E., et al.
Publicado: (2015)

QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics
por: Johnsen, Erik, et al.
Publicado: (2013)

The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study
por: Bodnar, Michael, et al.
Publicado: (2016)

Treatment of Acute Psychosis with Second-Generation Antipsychotics in a Patient with Left Temporal Lobe Lesion
por: Shehane, Richard, et al.
Publicado: (2018)

Phase-Specific and Lifetime Costs of Multiple Myeloma Among Older Adults in the US
por: Bhattacharya, Kaustuv, et al.
Publicado: (2021)

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
por: Kumra, Sanjiv, et al.
Publicado: (2008)

Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19
por: Rong, Yiran, et al.
Publicado: (2023)

Influence of different second generation antipsychotics on the QTc interval: A pragmatic study
por: Olsen, Roy E, et al.
Publicado: (2016)

Influence of first- and second-generation antipsychotics on anthropometric parameters of male psychiatric patients
por: Nkondo-Ndaba, Maseqhala P., et al.
Publicado: (2022)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

Arterial Stiffness in Patients Taking Second-generation Antipsychotics
por: Fındıklı, Ebru, et al.
Publicado: (2016)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020)

Association of Lithium and Second-Generation Antipsychotics with Neurocognition in Youth with Bipolar Disorder
por: Jiang, Xinyue, et al.
Publicado: (2022)

First-generation vs second-generation antipsychotic drugs: The ongoing saga
por: Gupta, Sumeet
Publicado: (2010)

Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics
por: Devlin, A M, et al.
Publicado: (2012)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021)

Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics
por: Oh, Jee-Eun, et al.
Publicado: (2012)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Overcoming barriers to monitoring patients taking second-generation antipsychotics
por: Peña, Anita, et al.
Publicado: (2018)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Combination treatment with second generation antipsychotics other than clozapine
por: Schmidt-Kraepelin, C.
Publicado: (2021)

Risk of Breast Cancer in Association with the Use of Second-generation Antipsychotics
por: Joo, Sung Woo, et al.
Publicado: (2022)

T23. ANTIPSYCHOTIC EXPOSURE AND STRIATAL FUNCTIONAL CONNECTIVITY IN PSYCHOSIS RELAPSE: A HYPOTHESIS GENERATING STUDY
por: Rubio, Jose, et al.
Publicado: (2020)

Prevalence of and factors associated with violations of a campus smoke-free policy: a cross-sectional survey of undergraduate students on a university campus in the USA
por: Ramachandran, Sujith, et al.
Publicado: (2020)

Diabetes Prevalence and Risk Factors in Patients With Chronic Mental Illness on Second-Generation Antipsychotics
por: Sahay, Priya, et al.
Publicado: (2021)

A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis
por: Marcinowicz, Piotr, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics
por: Moschny, Nicole, et al.
Publicado: (2021)

PIN40 Risk Factors for Severe Outcomes in COVID-19 Confirmed or Suspected Beneficiaries Enrolled in Mississippi Medicaid
por: Rong, Y., et al.
Publicado: (2021)

Efficacy and tolerance of second-generation antipsychotics in anorexia nervosa: A systematic scoping review
por: Thorey, Solène, et al.
Publicado: (2023)

Antipsychotics for Amphetamine Psychosis. A Systematic Review
por: Fluyau, Dimy, et al.
Publicado: (2019)

Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis
por: Zaremba, Malgorzata, et al.
Publicado: (2023)

Teetering on the Edge: Second-Degree Atrioventricular Block Following Long-Acting Second-Generation Antipsychotic
por: Harrisingh, Kamahl, et al.
Publicado: (2023)

Effectiveness of second generation antipsychotics: A systematic review of randomized trials
por: Johnsen, Erik, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_e1j41s0u750p921fm56itvm76u